Recent Blog Posts

View Post: VELCADE® (Bortezomib) for Injection to be Featured in Plenary ...
20 hours ago
Bortezomib plus melphalan-prednisone continues to demonstrate a survival benefit vs melphalan-prednisone in the phase III VISTA trial in previously untreated multiple myeloma after more than 3 years' follow-up and extensive subsequent ... The impact of cancer therapy cost and the accessibility of treatment are currently at the center of the debate on healthcare reform. Several abstracts at this year's ASH address the cost and convenience of VELCADE based therapy compared ...
View Blog: Centredaily.com: Technology - http://www.centredaily.com/business/technology/story/1076127.html

---

View Post: Treatment Trends For Multiple Myeloma – Part 3: Options For ...
24 Nov 2009 by Francie Diep  
... with multiple myeloma and had such great impact on the multiple myeloma research community that the National Comprehensive Cancer Network, a group of 21 United States cancer centers, considers treatment with melphalan, prednisone, ...
View Blog: The Myeloma Beacon - http://www.myelomabeacon.com/

---

View Post: Today's Bone Marrow Biopsy: Total Buzz Kill or Gentle Reminder ...
23 Nov 2009 by CEM  
It has been 90 days since my second autologous stem cell transplant- and 90 days since my last high dose melphalan infusion. My blood counts have recovered and. ... So, the biopsy felt like a “buzz kill” at first- killing my new sense of health and vitality, like a cancer-free person on top of life. But, that's not what I am. Instead, the biopsy was a gentle reminder that I live my life with Myeloma, in a precarious balance between health and sickness, and that I need to ...
View Blog: LongLifeNoodles - http://longlifenoodles.com/

---

View Post: Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ
29 Nov 2009
This clinical study is evaluating the Delcath PHP System for thee regional delivery of melphalan to the liver to treat patients with metastatic cutaneous and ouclar melanoma wjo have unressctable tumorq in the liver. ...
View Blog: tsanfere - http://www.liveinternet.ru/users/tsanfere/

---

View Post: Preclinical Studies in Support of Defibrotide for the Treatment of ...
19 Feb 2009 by Mitsiades, CS, Rouleau, C., Echart, C.,...  
The antithrombotic properties of defibrotide and its minimal hemorrhagic risk could serve for treatment of cancer-associated thrombotic complications. Given its cytoprotective effect on endothelium, we investigated whether defibrotide ... In cocultures of multiple myeloma cells with bone marrow stromal cells in vitro, defibrotide enhances the multiple myeloma cell sensitivity to melphalan and dexamethasone, and decreases multiple myeloma–bone marrow stromal cell adhesion ...
View Blog: Clinical Cancer Research recent issues - http://clincancerres.aacrjournals.org/

---

View Post: efficacy of melphalan and prednisone plus thalidomide in patients ...
19 Aug 2009 by Heroes & Survivors  
until recently, melphalan and prednisone were the standards of care in elderly patients with multiple myeloma. the addition of thalidomide to this combination demonstrated a survival benefit for patients age 65 to 75 years. ...
View Blog: Cancer Treatment Breaking News - http://www.heroesandsurvivors.com/

---

View Post: Defining regional infusion treatment strategies for extremity ...
18 May 2007 by Yoshimoto, Y., Augustine, CK, Yoo, JS,...  
... ability of analysis of the GST/glutathione pathway to predict response to chemotherapies like melphalan whose resistance is primarily mediated through a complex mechanism of detoxification. [Mol Cancer Ther 2007;6(5):1492–500] ...
View Blog: Molecular Cancer Therapeutics current issue - http://mct.aacrjournals.org/

---

View Post: Day -2 Celebrations
22 Nov 2009 by Bev and Ken  
Today I received Melphalan (alkeran) the M chemo of BEAM. It's now done. BEAM is over. Let the celebration begin. Maybe quietly. It's a milestone if I never have to take chemo again, but my mind can't let that go just yet. ...
View Blog: Ken's Fighting Cancer - http://kensfightingcancer.blogspot.com/

---

View Post: Stimulating The Body?s Defenses To Fight Cancer
23 Nov 2009 by i  
... joint pain, and/or thrombocytopenia), Paclitaxel (neurotoxicity), or Melphalan, with side effects which include irreversible bone marrow failure, bone marrow suppression). A woman stricken with ovarian cancer faces first surgery, ...
View Blog: ii - http://surgery-i.blogspot.com/

---